Prostate Cancer is the most common cancer in European men. Despite the dramatic improvements in early diagnostic and local treatment, one out of five prostate cancer patients will die from their disease. Therefore, it remains critical to improve the present strategy for advanced and metastatic prostate cancer.
In the DE-ESCALATE project, we will evaluate whether intermittent intensified androgen deprivation treatment (iADT) in metastatic prostate cancer is not inferior to continuous treatment in terms of oncological benefit while minimizing side effects and resource utilization and improving patient quality of life. The proposed clinical trial is designed to detect early if iADT has a negative impact on overall survival compared to continuous therapy.
If successful, the outcomes of the project will define a new evidence-based standard of care for metastatic hormone-sensitive prostate cancer. The proposed research could lead to improved patient survival and quality of life but also improve health system sustainability.
We are a multidisciplinary and multistakeholder consortium involving clinical oncologists, surgeons, health economists and patient representatives. The study design was successfully discussed with patients. This action is part of the Cancer Mission cluster of projects on ‘Diagnosis and treatment’.
© The DE-ESCALATE Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101104574 ). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Brussels, Be
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://deescalate-horizon.eu/
- Keywords
- London.
- HQ
- Brussels
De-Escalate Project Questions
De-Escalate Project's website is https://deescalate-horizon.eu/
De-Escalate Project's LinkedIn profile is https://be.linkedin.com/company/de-escalate-horizon
De-Escalate Project has
1 employees.
View email and phone details for 1
employees at De-Escalate Project.
De-Escalate Project's industry is
Hospitals and Health Care
De-Escalate Project's top competitors are
Viedoc,
Mvslim,
Zakatflow,
Cbig-Screen,
Strexit 2 Project,
Medschool Mentor,
Co-Captain_eu,
Liveration,
Eortc - European Organisation For Research And Treatment Of Cancer,
Legato Project.
De-Escalate Project's categories are Hospitals and Health Care
De-Escalate Project's founding year is 2023
